Cite
Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1/ROS/PKC-β axis.
MLA
Lu, Meili, et al. “Ginsenoside Rg1 Attenuates Diabetic Vascular Endothelial Dysfunction by Inhibiting the Calpain-1/ROS/PKC-β Axis.” Life Sciences, vol. 329, Sept. 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.lfs.2023.121972.
APA
Lu, M., Zhao, F., Ran, C., Xu, Y., Zhang, J., & Wang, H. (2023). Ginsenoside Rg1 attenuates diabetic vascular endothelial dysfunction by inhibiting the calpain-1/ROS/PKC-β axis. Life Sciences, 329, N.PAG. https://doi.org/10.1016/j.lfs.2023.121972
Chicago
Lu, Meili, Fang Zhao, Chenyang Ran, Yu Xu, Jingliang Zhang, and Hongxin Wang. 2023. “Ginsenoside Rg1 Attenuates Diabetic Vascular Endothelial Dysfunction by Inhibiting the Calpain-1/ROS/PKC-β Axis.” Life Sciences 329 (September): N.PAG. doi:10.1016/j.lfs.2023.121972.